Eversept Partners, LP

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.73B2026 Q3+ $125.4M options (notional, not included)
Positions111
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.50.3%

Eversept Partners, LP reported 111 positions worth $1.73B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: UTHR (9.5%). Biggest move: add RVTY ($56.0M).

10 / 111 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 UTHRUnited Therapeutics$176.0M9.46%324,729——+8.5%
▸ 2 EHCEncompass Health$131.5M7.07%1,082,316——+16.1%
▸ 3 ENSGEnsign$124.9M6.71%726,186——+9.4%
▸ 4 ABVXAbivax S.A.$109.0M5.86%1,100,655———
▸ 5 QQQPutInvesco QQQ Tr$99.9M notional5.37%135,000———
▸ 6 VERAVera Therapeutics$76.3M4.10%2,361,996——-13.0%
▸ 7 RVTYRevvity$68.8M3.70%449,790——+1.0%
▸ 8 NTRANatera$53.0M2.85%128,126——-30.2%
▸ 9 CTRECareTrust REIT$49.5M2.66%1,352,628——+2.2%
▸ 10 OHIOmega Healthcare Investors$46.7M2.51%1,008,565——+1.6%

Pro Feature

The remaining 101 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Eversept Partners, LP hold as of Q3 2026?

Eversept Partners, LP reported 111 positions worth $1.73B in its Q3 2026 13F filing. Largest positions: UTHR (9.5%), EHC (7.1%), ENSG (6.7%), ABVX (5.9%) and QQQ (5.4%).

What did Eversept Partners, LP buy in Q3 2026?

New positions: GH, WAT, GRAL, GDRX and ROIV (24 in all). Added to: RVTY, QQQ, OHI, ENSG and UTHR (32 in all).

What did Eversept Partners, LP sell in Q3 2026?

Reduced: IONS, TVTX, CLDX, NTRA and VRDN (48 in all). Sold out entirely: GSK, LLY, AMN, CELC and HUM (33 in all).

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.